Profluent

Profluent Bio is an AI-first protein design startup founded in 2022 and based in Berkeley, CA. The company leverages pioneering research in artificial intelligence and biology to develop machine learning models for reading and writing biomolecules for human health and industrial applications. With a focus on the biotechnology industry, Profluent Bio has garnered significant attention, receiving a $35.00M Series A investment on 21 March 2024. This round of funding included prominent investors such as Air Street Capital, Insight Partners, Spark Capital, and Jeff Dean, signifying confidence in the startup's potential. As an early-stage, well-funded venture, Profluent Bio consists of a team of world-class scientists, technologists, and entrepreneurs, driving impactful innovation in the biotech space.